NeoGenomics, Inc.
US ˙ NasdaqCM ˙ US64049M2098

SecurityNEO / NeoGenomics, Inc.
InstitutionCreative Planning
Latest Disclosed Ownership60,598 shares
Latest Disclosed Value $ 449,636
Creative Planning ownership in NEO / NeoGenomics, Inc.

On May 12, 2026 - Creative Planning filed a 13F-HR form disclosing ownership of 60,598 shares of NeoGenomics, Inc. (US:NEO) valued at $449,637 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 53,966 shares of NeoGenomics, Inc.. This represents a change in shares of 12.29% during the quarter. The current value of the position is $685,363 USD.

Creative Planning has a history of taking positions in derivatives of the underlying security (NEO) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

NEO / NeoGenomics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F NEOGENOMICS COM NEW 64049M209 60,598 6,632 12.29 450 -29.18 0.0003
2026-02-17 2025-12-31 13F NEOGENOMICS COM NEW 64049M209 53,966 10,027 22.82 635 87.02 0.0005
2025-11-14 2025-09-30 13F NEOGENOMICS COM NEW 64049M209 43,939 27,204 162.56 339 177.87 0.0003
2025-08-08 2025-06-30 13F NEOGENOMICS COM NEW 64049M209 16,735 2,840 20.44 122 -6.87 0.0001
2025-05-15 2025-03-31 13F NEOGENOMICS COM NEW 64049M209 13,895 -8,430 -37.76 132 -64.31 0.0001
2025-02-14 2024-12-31 13F NEOGENOMICS COM NEW 64049M209 22,325 -1,222 -5.19 368 5.76 0.0004
2024-10-11 2024-09-30 13F NEOGENOMICS COM NEW 64049M209 23,547 7,004 42.34 347 51.53 0.0003
2024-08-15 2024-06-30 13F NEOGENOMICS COM NEW 64049M209 16,543 -1,108 -6.28 229 -17.33 0.0002
2024-05-13 2024-03-31 13F NEOGENOMICS COM NEW 64049M209 17,651 747 4.42 277 1.47 0.0003
2024-02-14 2023-12-31 13F NEOGENOMICS COM NEW 64049M209 16,904 -85,108 -83.43 274 -78.23 0.0005
2023-11-16 2023-09-30 13F NEOGENOMICS COM NEW 64049M209 102,012 1,080 1.07 1,255 -22.64 0.0017
2023-07-21 2023-06-30 13F NEOGENOMICS COM NEW 64049M209 100,932 -566 -0.56 1,622 -8.26 0.0022
2023-05-15 2023-03-31 13F NEOGENOMICS COM NEW 64049M209 101,498 -7 -0.01 1,767 88.58 0.0025
2023-02-10 2022-12-31 13F NEOGENOMICS COM NEW 64049M209 101,505 36,268 55.59 938 66.73 0.0014
2022-11-03 2022-09-30 13F NEOGENOMICS COM NEW 64049M209 65,237 40,758 166.50 562 181.00 0.0010
2022-08-15 2022-06-30 13F NEOGENOMICS COM NEW 64049M209 24,479 12,727 108.30 200 39.86 0.0003
2022-05-16 2022-03-31 13F NEOGENOMICS COM NEW 64049M209 11,752 -222 -1.85 143 -65.04 0.0002
2022-02-11 2021-12-31 13F NEOGENOMICS COM NEW 64049M209 11,974 -1,739 -12.68 409 -38.22 0.0007
2021-11-10 2021-09-30 13F NEOGENOMICS COM NEW 64049M209 13,713 -6,402 -31.83 662 -27.09 0.0012
2021-08-04 2021-06-30 13F NEOGENOMICS COM NEW 64049M209 20,115 8,471 72.75 908 61.57 0.0016
2021-04-30 2021-03-31 13F CreativePlanning COM NEW 64049M209 11,644 3,228 38.36 562 24.06 0.0011
2021-01-29 2020-12-31 13F NEOGENOMICS COM NEW 64049M209 8,416 1,115 15.27 453 68.40 0.0010
2020-11-05 2020-09-30 13F NEOGENOMICS COM NEW 64049M209 7,301 7,301 269 0.0007
2017-10-17 2017-09-30 13F NEOGENOMICS COM NEW 64049M209 0 -3,500 -100.00 0 -100.00
2017-07-12 2017-06-30 13F NEOGENOMICS COM NEW 64049M209 3,500 -3,000 -46.15 31 -39.22 0.0002
2017-04-07 2017-03-31 13F NEOGENOMICS COM NEW 64049M209 6,500 0 0.00 51 -8.93 0.0003
2017-01-09 2016-12-31 13F NEOGENOMICS COM NEW 64049M209 6,500 2,500 62.50 56 69.70 0.0003
2016-10-12 2016-09-30 13F NEOGENOMICS COM NEW 64049M209 4,000 3,000 300.00 33 312.50 0.0002
2016-07-12 2016-06-30 13F NEOGENOMICS COM NEW 64049M209 1,000 -7,800 -88.64 8 -86.44 0.0001
2016-04-08 2016-03-31 13F NEOGENOMICS COM NEW 64049M209 8,800 0 0.00 59 -14.49 0.0005
2016-01-11 2015-12-31 13F NEOGENOMICS COM NEW 64049M209 8,800 8,000 1,000.00 69 1,280.00 0.0006
2015-10-09 2015-09-30 13F NEOGENOMICS COM NEW 64049M209 800 800 0.00 5 0.0000
2015-07-09 2015-06-30 13F NEOGENOMICS COM NEW 64049M209 0 -800 -100.00 0 -100.00
2015-04-13 2015-03-31 13F NEOGENOMICS COM NEW 64049M209 800 800 0.00 4 0.0000
2015-01-29 2014-12-31 13F NEOGENOMICS COM NEW 64049M209 0 -800 -100.00 0 -100.00
2014-10-10 2014-09-30 13F NEOGENOMICS COM NEW 64049M209 800 0 0.00 4 33.33 0.0000
2014-08-20 2014-06-30 13F NEOGENOMICS COM NEW 64049M209 800 500 166.67 3 200.00 0.0000
2014-04-11 2014-03-31 13F NEOGENOMICS COM NEW 64049M209 300 0 0.00 1 0.00 0.0000
2014-01-06 2013-12-31 13F NEOGENOMICS COM NEW 64049M209 300 300 1 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-04-30 2021-03-31 13F NEOGENOMICS COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-01-29 2020-12-31 13F NEOGENOMICS COM NEW Call 3,000 73 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.